3rd Quarter - Report

CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)

Firm
Client
Income
—
Expenses
$1,620,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to medication adherence, drug pricing transparency, and COVID testing and vaccination, including the Federal Retail Pharmacy Program. S. 1909, The Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R. 7213, The Equitable Community Access to Pharmacist Services Act P.L. 117-169, The Inflation Reduction Act of 2022

LobbyistCovered position, as disclosed
ROBERT BUTORA —
KAITLYN LANE —
YUJIN LEE —
JOY MCGLAUN —
SHANNON PENBERTHY —
AMY ROSENBAUM —
MELISSA SCHULMAN —
ROBERT TANNER WARBINTON —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 7213 (117th), S. 1909 (117th)

Taxation/Internal Revenue Code TAX

Issues related to corporate tax rate and the Work Opportunity Tax Credit. H.R. 1304 - American Innovation and R&D Competitiveness Act of 2021 P.L. 117-169, The Inflation Reduction Act of 2022

LobbyistCovered position, as disclosed
JOY MCGLAUN —
SHANNON PENBERTHY —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 1304 (117th)

Medicare/Medicaid MMM

Issues related to Medicare Part D, Medicare Advantage, Medicaid, the ESRD program, mental health, and telehealth. Issues related to reimbursement for COVID-19 testing, vaccination, and treatment. HR 3173, Improving Seniors Timely Access to Care Act. P.L. 117-169, The Inflation Reduction Act of 2022.

LobbyistCovered position, as disclosed
ROBERT BUTORA —
KAITLYN LANE —
YUJIN LEE —
JOY MCGLAUN —
SHANNON PENBERTHY —
AMY ROSENBAUM —
MELISSA SCHULMAN —
ROBERT TANNER WARBINTON —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 3173 (117th)

Insurance INS

Issues related to employer, small group and individual insurance markets, including surprise billing and ACA subsidies.

LobbyistCovered position, as disclosed
YUJIN LEE —
JOY MCGLAUN —
AMY ROSENBAUM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Labor Issues/Antitrust/Workplace LBR

Issues related to the competitive nature of the pharmacy benefit management industry and workforce issues, including reauthorization of the Workforce Innovation and Opportunity Act and national apprenticeship programs. H.R. 447 - The National Apprenticeship Act of 2021 S. 4295 - The Pharmacy Benefit Manager Transparency Act of 2022

LobbyistCovered position, as disclosed
ROBERT BUTORA —
YUJIN LEE —
JOY MCGLAUN —
SHANNON PENBERTHY —
AMY ROSENBAUM —
ROBERT TANNER WARBINTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 447 (117th), S. 4295 (117th)

Consumer Issues/Safety/Products CSP

Issues related to organized retail crime and product safety. HR 5502, The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers Act HR 4521, The United States Innovation and Competition Act of 2021 H.R. 7900, National Defense Authorization Act for Fiscal Year 2023. S. 5406, The Combatting Organized Retail Crime Act of 2022

LobbyistCovered position, as disclosed
ROBERT BUTORA —
SHANNON PENBERTHY —
ROBERT TANNER WARBINTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7900 (117th), S. 5406 (117th), H.R. 5502 (117th), H.R. 4521 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.